Premium
Sulfadimethoxine in giant freshwater prawns (Macrobrachium rosenbergii): an attempt to estimate the withdrawal time by a population pharmacokinetic approach
Author(s) -
Poapolathep A.,
Giorgi M.,
Toutain P. L.,
Poapolathep S.,
Imsilp K.,
Sakulthaew C.,
Wannapat N.,
Klangkaew N.
Publication year - 2017
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1111/jvp.12381
Subject(s) - macrobrachium rosenbergii , pharmacokinetics , bioavailability , withdrawal time , population , zoology , prawn , body weight , biology , chemistry , medicine , fishery , pharmacology , environmental health , colonoscopy , colorectal cancer , cancer
The fates of sulfadimethoxine ( SDM ) for different routes of administration were investigated in muscle tissue of giant freshwater prawns, Macrobrachium rosenbergii , following either intramuscular (i.m.) or gavage administration at a dosage of 50 mg/kg body weight (b.w.). The depletion patterns of SDM were also examined after medicated feed treatment at the feeding concentration of 10 g/kg of feed twice a day at a rate of 1% of total b.w. for five consecutive days. The concentration of SDM in prawn muscle tissue was measured using a high‐performance liquid chromatography ( HPLC ) equipped with ultraviolet detector. Noncompartmental analyses were used to estimate basic pharmacokinetic parameters for the i.m. and gavage data, while a population model was developed to analyze the entire data set including the feed group. Using the Monte Carlo simulations, the withdrawal times ( WT ) for the orally administered SDM in feed supplement were determined. Maximum concentration of SDM was significantly higher in the i.m. than in the gavage group, and the area under the curve ( AUC ) value for relative bioavailability following gavage administration was 25.6%. Using Monte Carlo simulation, for a maximum residue limit ( MRL ) of 0.1 μg/g, the WT for muscle after oral administration of SDM in feed was estimated to be 67 h, while for a MRL of 0.2 μg/g, the WT was estimated to be of 54 h.